BibTex format
@article{Arinaminpathy:2021:10.1136/bmjgh-2021-006114,
author = {Arinaminpathy, N and Nandi, A and Shibu, V and Nita, J and Sreenivas, N and Sameer, K and Puneet, D and Kiran, R and Bhavin, V and Raghuram, R and Kuldeep, Singh S},
doi = {10.1136/bmjgh-2021-006114},
journal = {BMJ Global Health},
pages = {1--10},
title = {Engaging with the private healthcare sector for the control of tuberculosis in India: Cost and cost-effectiveness},
url = {http://dx.doi.org/10.1136/bmjgh-2021-006114},
volume = {6},
year = {2021}
}
RIS format (EndNote, RefMan)
TY - JOUR
AB - BackgroundThe control of tuberculosis (TB) in India is complicated by the presence of a large, disorganised private sector where most patients first seek care. Following pilots in Mumbai and Patna (two major cities in India), an initiative known as the ‘Public Private Interface Agency’ (PPIA) is now being expanded across the country. We aimed to estimate the cost-effectiveness of scaling up PPIA operations, in line with India’s National Strategic Plan for TB control.MethodsFocusing on Mumbai and Patna, we collected cost data from implementing organisations in both cities and combined this data with models of TB transmission dynamics. Estimating the cost per DALY averted between 2014 (the start of PPIA scale-up) and 2025, we assessed cost-effectiveness using two willingness-to-pay approaches: a WHO-CHOICE threshold based on per-capita economic productivity, and a more stringent threshold incorporating opportunity costs in the health system.FindingsA PPIA scaled up to ultimately reach 50% of privately-treated TB patients in Mumbai and Patna would cost, respectively, USD 228 (95% C.I. 159 – 320) per DALY averted and USD 564 (95% C.I. 409 - 775) per DALY averted. In Mumbai, the PPIA would be cost-effective relative to all thresholds considered. In Patna, if focusing on adherence support, rather than on improved diagnosis, the PPIA would be cost-effective relative to all thresholds considered. These differences between sites arise from variations in the burden of drug resistance: amongst the services of a PPIA, improved diagnosis (including rapid tests with genotypic drug sensitivity testing) has greatest value in settings such as Mumbai, with a high burden of drug-resistant TB.ConclusionsTo accelerate decline in TB incidence, it is critical first to engage effectively with the private sector in India. Mechanisms such as the PPIA offer cost-effective ways of doing so, particularly when tailored to local settings.
AU - Arinaminpathy,N
AU - Nandi,A
AU - Shibu,V
AU - Nita,J
AU - Sreenivas,N
AU - Sameer,K
AU - Puneet,D
AU - Kiran,R
AU - Bhavin,V
AU - Raghuram,R
AU - Kuldeep,Singh S
DO - 10.1136/bmjgh-2021-006114
EP - 10
PY - 2021///
SN - 2059-7908
SP - 1
TI - Engaging with the private healthcare sector for the control of tuberculosis in India: Cost and cost-effectiveness
T2 - BMJ Global Health
UR - http://dx.doi.org/10.1136/bmjgh-2021-006114
UR - https://gh.bmj.com/content/6/10/e006114
VL - 6
ER -